Vandana Singh
·
July 25, 2025
Benzinga
Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease progression and cognitive decline.
read more
September 17, 2025
September 5, 2025
July 23, 2025
Bloomberg
August 27, 2025
June 20, 2025